IL147876A0 - Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients - Google Patents

Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients

Info

Publication number
IL147876A0
IL147876A0 IL14787600A IL14787600A IL147876A0 IL 147876 A0 IL147876 A0 IL 147876A0 IL 14787600 A IL14787600 A IL 14787600A IL 14787600 A IL14787600 A IL 14787600A IL 147876 A0 IL147876 A0 IL 147876A0
Authority
IL
Israel
Prior art keywords
agonists
therapy
pharmaceutically acceptable
acceptable derivatives
gabab receptors
Prior art date
Application number
IL14787600A
Other languages
English (en)
Original Assignee
Molteni & C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molteni & C filed Critical Molteni & C
Publication of IL147876A0 publication Critical patent/IL147876A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14787600A 1999-07-30 2000-06-30 Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients IL147876A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001715A IT1313585B1 (it) 1999-07-30 1999-07-30 Uso di agonisti dei recettori gabab per la terapia di mantenimentodell'astinenza da nicotina in soggetti nicotino-dipendenti.
PCT/EP2000/006120 WO2001008675A1 (fr) 1999-07-30 2000-06-30 Utilisation d'agonistes de recepteurs gabab et de leurs derives acceptables sur le plan pharmaceutique dans la therapie de maintien de l'abstinence a la nicotine chez les patients dependants de la nicotine

Publications (1)

Publication Number Publication Date
IL147876A0 true IL147876A0 (en) 2002-08-14

Family

ID=11383467

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14787600A IL147876A0 (en) 1999-07-30 2000-06-30 Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence-dependent patients
IL147876A IL147876A (en) 1999-07-30 2002-01-28 Use of agonists of gabab receptors or pharmaceutically acceptable derivatives thereof for the preparation of pharmaceutical compositions for reducing the wish of smoking in nicotine-dependent patients

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147876A IL147876A (en) 1999-07-30 2002-01-28 Use of agonists of gabab receptors or pharmaceutically acceptable derivatives thereof for the preparation of pharmaceutical compositions for reducing the wish of smoking in nicotine-dependent patients

Country Status (16)

Country Link
EP (1) EP1202727B1 (fr)
CN (1) CN1176650C (fr)
AT (1) ATE285763T1 (fr)
AU (1) AU6153400A (fr)
CA (1) CA2379752C (fr)
DE (1) DE60017147T2 (fr)
DK (1) DK1202727T3 (fr)
ES (1) ES2235913T3 (fr)
HK (1) HK1046849B (fr)
IL (2) IL147876A0 (fr)
IT (1) IT1313585B1 (fr)
PL (1) PL196334B1 (fr)
PT (1) PT1202727E (fr)
RU (1) RU2262352C2 (fr)
SI (1) SI1202727T1 (fr)
WO (1) WO2001008675A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019163A2 (fr) 2003-08-20 2005-03-03 Xenoport, Inc. Prodrogues a base de carbamate d'alkyle acyle, procede de synthese et utilisation
EP2354120A1 (fr) 2003-08-20 2011-08-10 XenoPort, Inc. Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires
WO2006050471A2 (fr) 2004-11-03 2006-05-11 Xenoport, Inc. Prodrogues d'acyloxyalkyl carbamate de l'acide 3-aminopropylsulfinique, et procedes de synthese et d'utilisation
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
JP4498407B2 (ja) 2006-12-22 2010-07-07 キヤノン株式会社 プロセスカートリッジ、電子写真画像形成装置、及び、電子写真感光体ドラムユニット
TWI369202B (en) 2008-01-25 2012-08-01 Xenoport Inc Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US7872046B2 (en) 2008-01-25 2011-01-18 Xenoport, Inc. Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
WO2010017498A1 (fr) 2008-08-07 2010-02-11 Xenoport, Inc. Procédés de synthèse de carbonates de n-hydroxysuccinimidyle
WO2010017504A1 (fr) 2008-08-07 2010-02-11 Xenoport, Inc. Procédés de synthèse de promédicaments de 1-(acyloxy)-alkylcarbamate
WO2010102071A1 (fr) 2009-03-03 2010-09-10 Xenoport, Inc. Formes posologiques orales à libération entretenue d'un promédicament de r-baclofène
CA2758245A1 (fr) 2009-04-17 2010-10-21 Xenoport, Inc. Derives d'acide gamma-aminobutyrique comme ligands des recepteurs gabab
WO2011081558A1 (fr) * 2009-08-21 2011-07-07 Komissarov Jury Vladimirovich Dispositif pour fumeurs permettant de renoncer à la tabagie
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
EP3761979A4 (fr) * 2018-04-06 2021-06-30 Ovid Therapeutics Inc. Utilisation de gaboxadol dans le traitement de troubles liés à l'usage de substances

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
PL353373A1 (en) 2003-11-17
DK1202727T3 (da) 2005-05-09
PL196334B1 (pl) 2007-12-31
DE60017147T2 (de) 2006-01-12
EP1202727B1 (fr) 2004-12-29
ES2235913T3 (es) 2005-07-16
EP1202727A1 (fr) 2002-05-08
DE60017147D1 (de) 2005-02-03
ITMI991715A1 (it) 2001-01-30
CA2379752A1 (fr) 2001-02-08
ITMI991715A0 (it) 1999-07-30
HK1046849B (zh) 2005-07-15
PT1202727E (pt) 2005-05-31
CA2379752C (fr) 2008-05-27
AU6153400A (en) 2001-02-19
IL147876A (en) 2007-06-17
WO2001008675A1 (fr) 2001-02-08
CN1377265A (zh) 2002-10-30
CN1176650C (zh) 2004-11-24
HK1046849A1 (en) 2003-01-30
SI1202727T1 (fr) 2005-08-31
IT1313585B1 (it) 2002-09-09
RU2262352C2 (ru) 2005-10-20
ATE285763T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
HK1046849A1 (en) Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence in nicotine-dependent patients gabab.
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MY130619A (en) Pharmaceutical formulations of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
AU1079701A (en) Oral transmucosal drug dosage using solid solution
NZ514464A (en) Apomorphine and sildenafil composition
MY127739A (en) Use of pramipexole for the treatment of addictive disorders
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
EA200001049A1 (ru) Новые способы лечения нервных расстройств
IL136415A (en) Transmucosal formulations of levosimendan
AU2204701A (en) Formulations of adenosine a1 agonists
AU9028098A (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
EP0397211A3 (fr) Administration percutanée de la 3'-azido-3'-déoxythymidine

Legal Events

Date Code Title Description
FF Patent granted